MARZE LUSH: Open Payments
NPI 1912127911 · ROCKLEDGE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 23 payments from 9 companies in 2025. Trend: 2023 $406 · 2024 $647 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $189 |
| Regeneron Healthcare Solutions, Inc. | 2 | $121 |
| Novartis Pharmaceuticals Corporation | 3 | $87 |
| GENZYME CORPORATION | 2 | $56 |
| KYOWA KIRIN, INC. | 1 | $25 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Botanix SB Inc | 1 | $16 |
Products named: SKYRIZI, DUPIXENT, COSENTYX, POTELIGEO, ILUMYA, NUZYRA, LITFULO, SOFDRA.
Industry payments across FL — which companies pay providers there.
